Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancer

Investigational New Drugs

Volumn 30, Issue 4, 2012, Pages 1671-1675

  Kang, Byung Woog ^a   Kim, Jong Gwang ^a   Chae, Yee Soo ^a   Lee, Yoo Jin ^a   Lee, Soo Jung ^a   Moon, Joon Ho ^a   Sohn, Sang Kyun ^a   Jung, Min Kyu ^a   Jeon, Seong Woo ^a   Jang, Yun Jin ^a   Seo, Jongduk ^a   Lee, Yong Hyun ^a   Kwon, Ohkyung ^a   Chung, Ho Young ^a   Yu, Wansik ^a  

^a Kyungpook National University Hospital   (South Korea)

Author keywords

Adjuvant chemotherapy; Cisplatin; Feasibility; Gastric cancer; S 1

Indexed keywords

CISPLATIN; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR;

ABDOMINAL PAIN; ADULT; AGED; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; ASTHENIA; CANCER ADJUVANT THERAPY; CANCER STAGING; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DIZZINESS; DRUG TOLERABILITY; ETHNIC GROUP; FATIGUE; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; INFECTION; KOREAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROPATHY; NEUTROPENIA; OVERALL SURVIVAL; PILOT STUDY; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SIDE EFFECT; STOMACH ADENOCARCINOMA; THROMBOCYTOPENIA; UREMIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OXONIC ACID; PILOT PROJECTS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TEGAFUR; YOUNG ADULT;

EID: 84866742969     PISSN: 01676997     EISSN: 15730646     Source Type: Journal    
DOI: 10.1007/s10637-011-9729-y     Document Type: Article

References (17)

1. Oba K (2009) Efficacy of adjuvant chemotherapy using tegafurbased regimen for curatively resected gastric cancer: update of a meta-analysis. Int J Clin Oncol 14:85-89
2. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725-730
3. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, MAGIC Trial Participants (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11-20
4. Kubota T (2008) The role of S-1 in the treatment of gastric cancer. Br J Canc 98:1301-1304
5. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810-1820
6. Koizumi W, Narahara H, Hara TT, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, Toh Y, Nagaie T, Takagi S, Yamamura Y, Yanaoka K, Orita H, Takeuchi M (2008) S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 9:215-221
7. Kodera Y, Ishiyama A, Yoshikawa T, Kinoshita T, Ito S, Yokoyama H, Mochizuki Y, Ito H, Tsuburaya A, Sakamoto J, Nakao A (2010) A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703). Gastric Canc 13:197-203
8. Lee JL, Kang HJ, Kang YK, Ryu MH, Chang HM, Kim TW, Sohn HJ, Kim H, Lee JS (2008) Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer. Canc Chemother Pharmacol 61:837-845
9. Takahari D, Hamaguchi T, Yoshimura K, Katai H, Ito S, Fuse N, Kinoshita T, Yasui H, Terashima M, Goto M, Tanigawa N, Shirao K, Sano T, Sasako M (2010) Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer. Canc Chemother Pharmacol
10. Greene FL (2003) TNM staging for malignancies of the digestive tract: 2003 changes and beyond. Semin Surg Oncol 21:23-29
11. Saif MW, Syrigos KN, Katirtzoglou NA (2009) S-1: a promising new oral fluoropyrimidine derivative. Expet Opin Investig Drugs 18:335-348
12. Hejna M, Wohrer S, Schmidinger M, Raderer M (2006) Postoperative chemotherapy for gastric cancer. Oncologist 11:136-145
13. Shirasaka T, Shimamoto Y, Ohshimo H, Saito H, Fukushima M (1993) Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo. Canc Chemother Pharmacol 32:167-172
14. De Vita F, Giuliani F, Galizia G, Belli C, Aurilio G, Santabarbara G, Ciardiello F, Catalano G, Orditura M (2007) Neo-adjuvant and adjuvant chemotherapy of gastric cancer. Ann Oncol 18 Suppl 6: vi120-vi123
15. De Vita F, Vecchione L, Galizia G, Di Martino N, Fabozzi T, Catalano G, Ciardiello F, Orditura M (2009) Perspectives in adjuvant therapy of gastric cancer. Oncology 77 Suppl 1:38-42
16. Lee SS, Jeung HC, Chung HC, Noh SH, Hyung WJ, Ahn JY, Rha SY (2010) A pilot study of S-1 plus cisplatin versus 5-fluorouracil plus cisplatin for postoperative chemotherapy in histological stage IIIB-IV (M0) gastric cancer. Investig New Drugs
17. Koizumi W, Tanabe S, Saigenji K, Ohtsu A, Boku N, Nagashima F, Shirao K, Matsumura Y, Gotoh M (2003) Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer. Br J Canc 89:2207-2212